![PRD_000293 PRD_000293](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000293.svg) | PRD_000293 | Name: | INHIBITOR AC-ESMD-CHO | Formula: | C19 H32 N4 O10 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000295 PRD_000295](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000295.svg) | PRD_000295 | Name: | GLU-VAL-DEHYDROXYMETHYLASPARTIC ACID INHIBITOR | Formula: | C23 H30 Cl N3 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000296 PRD_000296](https://data.pdbj.org/pdbjplus/data/cc/svg/0GQ.svg) | PRD_000296 | Name: | 4-amino-N-{(1R,8R,9R,13R)-16-(4-amino-2-methylpyrimidin-5-yl)-1-benzyl-8-(cyclohexylmethyl)-9-hydroxy-13-[(1S)-1-methylpropyl]-2,6,11,14-tetraoxo-3,7,12,15-tetraazahexadec-1-yl}piperidine-1-carboxamide | Formula: | C41 H64 N10 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000297 PRD_000297](https://data.pdbj.org/pdbjplus/data/cc/svg/0GR.svg) | PRD_000297 | Name: | N-(furan-2-ylcarbonyl)-L-leucyl-L-tryptophan | Formula: | C22 H25 N3 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000298 PRD_000298](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000298.svg) | PRD_000298 | Name: | N-[(2R)-3-phenyl-2-{[L-prolyl-L-phenylalanyl-3-(1H-imidazol-3-ium-4-yl)-L-alanyl]amino}propyl]-L-phenylalanyl-L-valyltyrosine | Formula: | C58 H72 N12 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000300 PRD_000300](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000300.svg) | PRD_000300 | Name: | N-acetyl-L-isoleucyl-L-alpha-glutamyl-N-[(1S)-2-carboxy-1-formylethyl]-L-prolinamide | Formula: | C22 H36 N4 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000301 PRD_000301](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000301.svg) | PRD_000301 | Name: | N-(2-oxoethyl)-L-isoleucyl-L-alpha-glutamyl-N-[(1R)-2-carboxy-1-formylethyl]-L-threoninamide | Formula: | C21 H36 N4 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000306 PRD_000306](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000306.svg) | PRD_000306 | Name: | KPFS-(CH2-NH)-LQF peptidomimetic inhibitor of PfPM1 | Formula: | C49 H77 N10 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000307 PRD_000307](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000307.svg) | PRD_000307 | Name: | N-acetyl-6-ammonio-L-norleucyl-L-glutaminyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-leucinamide | Formula: | C26 H52 Cl N9 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000308 PRD_000308](https://data.pdbj.org/pdbjplus/data/cc/svg/0HT.svg) | PRD_000308 | Name: | methyl N-[(2S,3S)-3-amino-2-hydroxy-5-methylhexyl]-L-valyl-L-isoleucyl-L-phenylalaninate | Formula: | C28 H48 N4 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000309 PRD_000309](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000309.svg) | PRD_000309 | Name: | L-leucyl-N-(2-oxopropyl)-L-phenylalaninamide | Formula: | C26 H31 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000310 PRD_000310](https://data.pdbj.org/pdbjplus/data/cc/svg/EP0.svg) | PRD_000310 | Name: | N-[(3R)-4-ethoxy-3-hydroxy-4-oxobutanoyl]-L-isoleucyl-L-proline | Formula: | C17 H28 N2 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000312 PRD_000312](https://data.pdbj.org/pdbjplus/data/cc/svg/0I5.svg) | PRD_000312 | Name: | N-[(3S)-1-fluoro-2-oxo-5-phenylpentan-3-yl]-N~2~-(morpholin-4-ylcarbonyl)-L-leucinamide | Formula: | C22 H32 F N3 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000313 PRD_000313](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000313.svg) | PRD_000313 | Name: | MeOSuc-Ala-Ala-Pro-boroIle | Formula: | C21 H37 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000314 PRD_000314](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000314.svg) | PRD_000314 | Name: | METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID | Formula: | C18 H31 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000315 PRD_000315](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000315.svg) | PRD_000315 | Name: | O-methylsuccinyl-alanyl-alanyl-prolyl-borophenylalanine | Formula: | C24 H35 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000316 PRD_000316](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000316.svg) | PRD_000316 | Name: | METHOXYSUCCINYL-ALA-ALA-PRO-VALINE BORONIC ACID | Formula: | C20 H35 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000317 PRD_000317](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000317.svg) | PRD_000317 | Name: | N-(4-methoxy-4-oxobutanoyl)-L-alanyl-L-alanyl-N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-L-prolinamide | Formula: | C21 H37 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000318 PRD_000318](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000318.svg) | PRD_000318 | Name: | N-(4-methoxy-4-oxobutanoyl)-L-alanyl-L-alanyl-N-[(1R)-1-(dihydroxyboranyl)pentyl]-L-prolinamide | Formula: | C21 H37 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000319 PRD_000319](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000319.svg) | PRD_000319 | Name: | methyl N-{(2S,4S,5S)-5-[(L-alanyl-L-alanyl)amino]-2-benzyl-4-hydroxy-6-phenylhexanoyl}-L-valyl-L-valinate | Formula: | C36 H53 N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000320 PRD_000320](https://data.pdbj.org/pdbjplus/data/cc/svg/PSI.svg) | PRD_000320 | Name: | methyl N-{(4S,5S)-5-[(L-alanyl-L-alanyl)amino]-4-hydroxy-6-phenylhexanoyl}-L-valyl-L-valinate | Formula: | C29 H47 N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000321 PRD_000321](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000321.svg) | PRD_000321 | Name: | N-{(2S)-2-[(L-asparaginyl-L-leucyl)amino]-1,1-dihydroxy-4-methylpentyl}-L-threonyl-L-glutaminyl-L-isoleucine | Formula: | C31 H58 N8 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000322 PRD_000322](https://data.pdbj.org/pdbjplus/data/cc/svg/0IT.svg) | PRD_000322 | Name: | amino({(4S)-4-[({(3S)-3-[(benzylsulfonyl)amino]-2-oxopiperidin-1-yl}acetyl)amino]-5-oxopentyl}amino)methaniminium | Formula: | C20 H31 N6 O5 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000324 PRD_000324](https://data.pdbj.org/pdbjplus/data/cc/svg/0IV.svg) | PRD_000324 | Name: | 2-{(3S)-3-[(benzylsulfonyl)amino]-2-oxopiperidin-1-yl}-N-{(2S)-1-[(3R)-1-carbamimidoylpiperidin-3-yl]-3-oxopropan-2-yl}acetamide | Formula: | C23 H34 N6 O5 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000325 PRD_000325](https://data.pdbj.org/pdbjplus/data/cc/svg/0IW.svg) | PRD_000325 | Name: | Nalpha-[(4-methylpiperazin-1-yl)carbonyl]-N-[(3S)-1-phenyl-5-(phenylsulfonyl)pentan-3-yl]-L-phenylalaninamide | Formula: | C32 H40 N4 O4 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|